APO Research

APO RESEARCH · REPORT

Parenteral Drugs Glass Packaging

Selected research

Market Analysis & Forecast

Global Parenteral Drugs Glass Packaging Market Analysis and Forecast 2026-2032

Market perspective

The global Parenteral Drugs Glass Packaging market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Parenteral Drugs Glass Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Parenteral Drugs Glass Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Parenteral Drugs Glass Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Parenteral Drugs Glass Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Parenteral Drugs Glass Packaging include Ypsomed Holding AG, Gerresheimer AG, SiO2 Medical Products, Schott AG, Ompi Stevanato Group, Becton Dickinson and Company, MeadWestvaco Corporation, Unilife Corporation Inc and West Pharmaceutical Services, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Parenteral Drugs Glass Packaging, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Parenteral Drugs Glass Packaging, also provides the sales of main regions and countries. Of the upcoming market potential for Parenteral Drugs Glass Packaging, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Parenteral Drugs Glass Packaging sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Parenteral Drugs Glass Packaging market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Parenteral Drugs Glass Packaging sales, projected growth trends, production technology, application and end-user industry.

Parenteral Drugs Glass Packaging Segment by Company

Ypsomed Holding AG

Gerresheimer AG

SiO2 Medical Products

Schott AG

Ompi Stevanato Group

Becton Dickinson and Company

MeadWestvaco Corporation

Unilife Corporation Inc

West Pharmaceutical Services

Terumo Corporation

Berry Plastics Corporation

Owens-Illinois

RPC Group

Graphic Packaging Group

Parenteral Drugs Glass Packaging Segment by Type

Polyvinyl Chloride (PVC)

Polyolefin

Parenteral Drugs Glass Packaging Segment by Application

Large Volume Parenteral (LVP)

Small Volume Parenteral (SVP)

Parenteral Drugs Glass Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Drugs Glass Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parenteral Drugs Glass Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Drugs Glass Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Parenteral Drugs Glass Packaging in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Parenteral Drugs Glass Packaging manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Parenteral Drugs Glass Packaging sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Parenteral Drugs Glass Packaging Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Polyvinyl Chloride (PVC) Major Manufacturers Table 3. Polyolefin Major Manufacturers Table 4. Global Parenteral Drugs Glass Packaging Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Large Volume Parenteral (LVP) Major Manufacturers Table 6. Small Volume Parenteral (SVP) Major Manufacturers Table 7. Parenteral Drugs Glass Packaging Industry Trends Table 8. Parenteral Drugs Glass Packaging Industry Drivers Table 9. Parenteral Drugs Glass Packaging Industry Opportunities and Challenges Table 10. Parenteral Drugs Glass Packaging Industry Restraints Table 11. Global Parenteral Drugs Glass Packaging Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Parenteral Drugs Glass Packaging Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Parenteral Drugs Glass Packaging Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Parenteral Drugs Glass Packaging Revenue Market Share by Region (2021-2026) Table 15. Global Parenteral Drugs Glass Packaging Revenue Market Share by Region (2027-2032) Table 16. Global Parenteral Drugs Glass Packaging Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Parenteral Drugs Glass Packaging Sales by Region (2021-2026) & (k units) Table 18. Global Parenteral Drugs Glass Packaging Sales by Region (2027-2032) & (k units) Table 19. Global Parenteral Drugs Glass Packaging Sales Market Share by Region (2021-2026) Table 20. Global Parenteral Drugs Glass Packaging Sales Market Share by Region (2027-2032) Table 21. Global Parenteral Drugs Glass Packaging Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Parenteral Drugs Glass Packaging Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Parenteral Drugs Glass Packaging Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Parenteral Drugs Glass Packaging Sales Market Share by Manufacturers (2021-2026) Table 25. Global Parenteral Drugs Glass Packaging Sales Price (USD/unit) of Manufacturers (2021-2026) Table 26. Global Parenteral Drugs Glass Packaging Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Parenteral Drugs Glass Packaging Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Parenteral Drugs Glass Packaging Manufacturers, Product Type & Application Table 29. Global Parenteral Drugs Glass Packaging Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Parenteral Drugs Glass Packaging by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Parenteral Drugs Glass Packaging Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Parenteral Drugs Glass Packaging Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Parenteral Drugs Glass Packaging Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Parenteral Drugs Glass Packaging Revenue Market Share by Type (2021-2026) Table 36. Global Parenteral Drugs Glass Packaging Revenue Market Share by Type (2027-2032) Table 37. Global Parenteral Drugs Glass Packaging Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Parenteral Drugs Glass Packaging Sales by Type (2021-2026) & (k units) Table 39. Global Parenteral Drugs Glass Packaging Sales by Type (2027-2032) & (k units) Table 40. Global Parenteral Drugs Glass Packaging Sales Market Share by Type (2021-2026) Table 41. Global Parenteral Drugs Glass Packaging Sales Market Share by Type (2027-2032) Table 42. Global Parenteral Drugs Glass Packaging Price by Type (2021-2026) & (USD/unit) Table 43. Global Parenteral Drugs Glass Packaging Price by Type (2027-2032) & (USD/unit) Table 44. Global Parenteral Drugs Glass Packaging Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Parenteral Drugs Glass Packaging Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Parenteral Drugs Glass Packaging Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Parenteral Drugs Glass Packaging Revenue Market Share by Application (2021-2026) Table 48. Global Parenteral Drugs Glass Packaging Revenue Market Share by Application (2027-2032) Table 49. Global Parenteral Drugs Glass Packaging Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Parenteral Drugs Glass Packaging Sales by Application (2021-2026) & (k units) Table 51. Global Parenteral Drugs Glass Packaging Sales by Application (2027-2032) & (k units) Table 52. Global Parenteral Drugs Glass Packaging Sales Market Share by Application (2021-2026) Table 53. Global Parenteral Drugs Glass Packaging Sales Market Share by Application (2027-2032) Table 54. Global Parenteral Drugs Glass Packaging Price by Application (2021-2026) & (USD/unit) Table 55. Global Parenteral Drugs Glass Packaging Price by Application (2027-2032) & (USD/unit) Table 56. Ypsomed Holding AG Company Information Table 57. Ypsomed Holding AG Business Overview Table 58. Ypsomed Holding AG Parenteral Drugs Glass Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 59. Ypsomed Holding AG Parenteral Drugs Glass Packaging Product Portfolio Table 60. Ypsomed Holding AG Recent Development Table 61. Gerresheimer AG Company Information Table 62. Gerresheimer AG Business Overview Table 63. Gerresheimer AG Parenteral Drugs Glass Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 64. Gerresheimer AG Parenteral Drugs Glass Packaging Product Portfolio Table 65. Gerresheimer AG Recent Development Table 66. SiO2 Medical Products Company Information Table 67. SiO2 Medical Products Business Overview Table 68. SiO2 Medical Products Parenteral Drugs Glass Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. SiO2 Medical Products Parenteral Drugs Glass Packaging Product Portfolio Table 70. SiO2 Medical Products Recent Development Table 71. Schott AG Company Information Table 72. Schott AG Business Overview Table 73. Schott AG Parenteral Drugs Glass Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Schott AG Parenteral Drugs Glass Packaging Product Portfolio Table 75. Schott AG Recent Development Table 76. Ompi Stevanato Group Company Information Table 77. Ompi Stevanato Group Business Overview Table 78. Ompi Stevanato Group Parenteral Drugs Glass Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Ompi Stevanato Group Parenteral Drugs Glass Packaging Product Portfolio Table 80. Ompi Stevanato Group Recent Development Table 81. Becton Dickinson and Company Company Information Table 82. Becton Dickinson and Company Business Overview Table 83. Becton Dickinson and Company Parenteral Drugs Glass Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Becton Dickinson and Company Parenteral Drugs Glass Packaging Product Portfolio Table 85. Becton Dickinson and Company Recent Development Table 86. MeadWestvaco Corporation Company Information Table 87. MeadWestvaco Corporation Business Overview Table 88. MeadWestvaco Corporation Parenteral Drugs Glass Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. MeadWestvaco Corporation Parenteral Drugs Glass Packaging Product Portfolio Table 90. MeadWestvaco Corporation Recent Development Table 91. Unilife Corporation Inc Company Information Table 92. Unilife Corporation Inc Business Overview Table 93. Unilife Corporation Inc Parenteral Drugs Glass Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Unilife Corporation Inc Parenteral Drugs Glass Packaging Product Portfolio Table 95. Unilife Corporation Inc Recent Development Table 96. West Pharmaceutical Services Company Information Table 97. West Pharmaceutical Services Business Overview Table 98. West Pharmaceutical Services Parenteral Drugs Glass Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. West Pharmaceutical Services Parenteral Drugs Glass Packaging Product Portfolio Table 100. West Pharmaceutical Services Recent Development Table 101. Terumo Corporation Company Information Table 102. Terumo Corporation Business Overview Table 103. Terumo Corporation Parenteral Drugs Glass Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Terumo Corporation Parenteral Drugs Glass Packaging Product Portfolio Table 105. Terumo Corporation Recent Development Table 106. Berry Plastics Corporation Company Information Table 107. Berry Plastics Corporation Business Overview Table 108. Berry Plastics Corporation Parenteral Drugs Glass Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Berry Plastics Corporation Parenteral Drugs Glass Packaging Product Portfolio Table 110. Berry Plastics Corporation Recent Development Table 111. Owens-Illinois Company Information Table 112. Owens-Illinois Business Overview Table 113. Owens-Illinois Parenteral Drugs Glass Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Owens-Illinois Parenteral Drugs Glass Packaging Product Portfolio Table 115. Owens-Illinois Recent Development Table 116. RPC Group Company Information Table 117. RPC Group Business Overview Table 118. RPC Group Parenteral Drugs Glass Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. RPC Group Parenteral Drugs Glass Packaging Product Portfolio Table 120. RPC Group Recent Development Table 121. Graphic Packaging Group Company Information Table 122. Graphic Packaging Group Business Overview Table 123. Graphic Packaging Group Parenteral Drugs Glass Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Graphic Packaging Group Parenteral Drugs Glass Packaging Product Portfolio Table 125. Graphic Packaging Group Recent Development Table 126. North America Parenteral Drugs Glass Packaging Revenue by Type (2021-2026) & (US$ Million) Table 127. North America Parenteral Drugs Glass Packaging Revenue by Type (2027-2032) & (US$ Million) Table 128. North America Parenteral Drugs Glass Packaging Sales by Type (2021-2026) & (k units) Table 129. North America Parenteral Drugs Glass Packaging Sales by Type (2027-2032) & (k units) Table 130. North America Parenteral Drugs Glass Packaging Sales Price by Type (2021-2026) & (USD/unit) Table 131. North America Parenteral Drugs Glass Packaging Sales Price by Type (2027-2032) & (USD/unit) Table 132. North America Parenteral Drugs Glass Packaging Revenue by Application (2021-2026) & (US$ Million) Table 133. North America Parenteral Drugs Glass Packaging Revenue by Application (2027-2032) & (US$ Million) Table 134. North America Parenteral Drugs Glass Packaging Sales by Application (2021-2026) & (k units) Table 135. North America Parenteral Drugs Glass Packaging Sales by Application (2027-2032) & (k units) Table 136. North America Parenteral Drugs Glass Packaging Sales Price by Application (2021-2026) & (USD/unit) Table 137. North America Parenteral Drugs Glass Packaging Sales Price by Application (2027-2032) & (USD/unit) Table 138. North America Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. North America Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. North America Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. North America Parenteral Drugs Glass Packaging Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 142. North America Parenteral Drugs Glass Packaging Sales by Country (2021-2026) & (k units) Table 143. North America Parenteral Drugs Glass Packaging Sales by Country (2027-2032) & (k units) Table 144. North America Parenteral Drugs Glass Packaging Sales Price by Country (2021-2026) & (USD/unit) Table 145. North America Parenteral Drugs Glass Packaging Sales Price by Country (2027-2032) & (USD/unit) Table 146. United States Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 147. Canada Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 148. Mexico Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 149. Europe Parenteral Drugs Glass Packaging Revenue by Type (2021-2026) & (US$ Million) Table 150. Europe Parenteral Drugs Glass Packaging Revenue by Type (2027-2032) & (US$ Million) Table 151. Europe Parenteral Drugs Glass Packaging Sales by Type (2021-2026) & (k units) Table 152. Europe Parenteral Drugs Glass Packaging Sales by Type (2027-2032) & (k units) Table 153. Europe Parenteral Drugs Glass Packaging Sales Price by Type (2021-2026) & (USD/unit) Table 154. Europe Parenteral Drugs Glass Packaging Sales Price by Type (2027-2032) & (USD/unit) Table 155. Europe Parenteral Drugs Glass Packaging Revenue by Application (2021-2026) & (US$ Million) Table 156. Europe Parenteral Drugs Glass Packaging Revenue by Application (2027-2032) & (US$ Million) Table 157. Europe Parenteral Drugs Glass Packaging Sales by Application (2021-2026) & (k units) Table 158. Europe Parenteral Drugs Glass Packaging Sales by Application (2027-2032) & (k units) Table 159. Europe Parenteral Drugs Glass Packaging Sales Price by Application (2021-2026) & (USD/unit) Table 160. Europe Parenteral Drugs Glass Packaging Sales Price by Application (2027-2032) & (USD/unit) Table 161. Europe Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Europe Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Europe Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Europe Parenteral Drugs Glass Packaging Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 165. Europe Parenteral Drugs Glass Packaging Sales by Country (2021-2026) & (k units) Table 166. Europe Parenteral Drugs Glass Packaging Sales by Country (2027-2032) & (k units) Table 167. Europe Parenteral Drugs Glass Packaging Sales Price by Country (2021-2026) & (USD/unit) Table 168. Europe Parenteral Drugs Glass Packaging Sales Price by Country (2027-2032) & (USD/unit) Table 169. Germany Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 170. France Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 171. U.K. Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 172. Italy Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 173. Russia Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 174. Spain Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 175. Netherlands Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 176. Switzerland Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 177. Sweden Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 178. Poland Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 179. China Parenteral Drugs Glass Packaging Revenue by Type (2021-2026) & (US$ Million) Table 180. China Parenteral Drugs Glass Packaging Revenue by Type (2027-2032) & (US$ Million) Table 181. China Parenteral Drugs Glass Packaging Sales by Type (2021-2026) & (k units) Table 182. China Parenteral Drugs Glass Packaging Sales by Type (2027-2032) & (k units) Table 183. China Parenteral Drugs Glass Packaging Sales Price by Type (2021-2026) & (USD/unit) Table 184. China Parenteral Drugs Glass Packaging Sales Price by Type (2027-2032) & (USD/unit) Table 185. China Parenteral Drugs Glass Packaging Revenue by Application (2021-2026) & (US$ Million) Table 186. China Parenteral Drugs Glass Packaging Revenue by Application (2027-2032) & (US$ Million) Table 187. China Parenteral Drugs Glass Packaging Sales by Application (2021-2026) & (k units) Table 188. China Parenteral Drugs Glass Packaging Sales by Application (2027-2032) & (k units) Table 189. China Parenteral Drugs Glass Packaging Sales Price by Application (2021-2026) & (USD/unit) Table 190. China Parenteral Drugs Glass Packaging Sales Price by Application (2027-2032) & (USD/unit) Table 191. Asia Parenteral Drugs Glass Packaging Revenue by Type (2021-2026) & (US$ Million) Table 192. Asia Parenteral Drugs Glass Packaging Revenue by Type (2027-2032) & (US$ Million) Table 193. Asia Parenteral Drugs Glass Packaging Sales by Type (2021-2026) & (k units) Table 194. Asia Parenteral Drugs Glass Packaging Sales by Type (2027-2032) & (k units) Table 195. Asia Parenteral Drugs Glass Packaging Sales Price by Type (2021-2026) & (USD/unit) Table 196. Asia Parenteral Drugs Glass Packaging Sales Price by Type (2027-2032) & (USD/unit) Table 197. Asia Parenteral Drugs Glass Packaging Revenue by Application (2021-2026) & (US$ Million) Table 198. Asia Parenteral Drugs Glass Packaging Revenue by Application (2027-2032) & (US$ Million) Table 199. Asia Parenteral Drugs Glass Packaging Sales by Application (2021-2026) & (k units) Table 200. Asia Parenteral Drugs Glass Packaging Sales by Application (2027-2032) & (k units) Table 201. Asia Parenteral Drugs Glass Packaging Sales Price by Application (2021-2026) & (USD/unit) Table 202. Asia Parenteral Drugs Glass Packaging Sales Price by Application (2027-2032) & (USD/unit) Table 203. Asia Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. Asia Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 205. Asia Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 206. Asia Parenteral Drugs Glass Packaging Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 207. Asia Parenteral Drugs Glass Packaging Sales by Country (2021-2026) & (k units) Table 208. Asia Parenteral Drugs Glass Packaging Sales by Country (2027-2032) & (k units) Table 209. Asia Parenteral Drugs Glass Packaging Sales Price by Country (2021-2026) & (USD/unit) Table 210. Asia Parenteral Drugs Glass Packaging Sales Price by Country (2027-2032) & (USD/unit) Table 211. Japan Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 212. South Korea Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 213. India Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 214. Australia Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 215. Taiwan Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 216. Southeast Asia Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 217. SAMEA Parenteral Drugs Glass Packaging Revenue by Type (2021-2026) & (US$ Million) Table 218. SAMEA Parenteral Drugs Glass Packaging Revenue by Type (2027-2032) & (US$ Million) Table 219. SAMEA Parenteral Drugs Glass Packaging Sales by Type (2021-2026) & (k units) Table 220. SAMEA Parenteral Drugs Glass Packaging Sales by Type (2027-2032) & (k units) Table 221. SAMEA Parenteral Drugs Glass Packaging Sales Price by Type (2021-2026) & (USD/unit) Table 222. SAMEA Parenteral Drugs Glass Packaging Sales Price by Type (2027-2032) & (USD/unit) Table 223. SAMEA Parenteral Drugs Glass Packaging Revenue by Application (2021-2026) & (US$ Million) Table 224. SAMEA Parenteral Drugs Glass Packaging Revenue by Application (2027-2032) & (US$ Million) Table 225. SAMEA Parenteral Drugs Glass Packaging Sales by Application (2021-2026) & (k units) Table 226. SAMEA Parenteral Drugs Glass Packaging Sales by Application (2027-2032) & (k units) Table 227. SAMEA Parenteral Drugs Glass Packaging Sales Price by Application (2021-2026) & (USD/unit) Table 228. SAMEA Parenteral Drugs Glass Packaging Sales Price by Application (2027-2032) & (USD/unit) Table 229. SAMEA Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 230. SAMEA Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 231. SAMEA Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 232. SAMEA Parenteral Drugs Glass Packaging Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 233. SAMEA Parenteral Drugs Glass Packaging Sales by Country (2021-2026) & (k units) Table 234. SAMEA Parenteral Drugs Glass Packaging Sales by Country (2027-2032) & (k units) Table 235. SAMEA Parenteral Drugs Glass Packaging Sales Price by Country (2021-2026) & (USD/unit) Table 236. SAMEA Parenteral Drugs Glass Packaging Sales Price by Country (2027-2032) & (USD/unit) Table 237. Brazil Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 238. Argentina Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 239. Chile Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 240. Colombia Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 241. Peru Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 242. Saudi Arabia Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 243. Israel Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 244. UAE Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 245. Turkey Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 246. Iran Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 247. Egypt Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Table 248. Key Raw Materials Table 249. Raw Materials Key Suppliers Table 250. Parenteral Drugs Glass Packaging Distributors List Table 251. Parenteral Drugs Glass Packaging Customers List Table 252. Research Programs/Design for This Report Table 253. Authors List of This Report Table 254. Secondary Sources Table 255. Primary Sources List of Figures Figure 1. Parenteral Drugs Glass Packaging Image Figure 2. Global Parenteral Drugs Glass Packaging Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Parenteral Drugs Glass Packaging Market Size Share 2021 VS 2025 VS 2032 Figure 4. Polyvinyl Chloride (PVC) Image Figure 5. Polyolefin Image Figure 6. Global Parenteral Drugs Glass Packaging Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Parenteral Drugs Glass Packaging Market Size Share 2021 VS 2025 VS 2032 Figure 8. Large Volume Parenteral (LVP) Image Figure 9. Small Volume Parenteral (SVP) Image Figure 10. Global Parenteral Drugs Glass Packaging Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Parenteral Drugs Glass Packaging Revenue (2021-2032) & (US$ Million) Figure 12. Global Parenteral Drugs Glass Packaging Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Parenteral Drugs Glass Packaging Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Parenteral Drugs Glass Packaging Revenue Market Share by Region (2021-2032) Figure 15. Global Parenteral Drugs Glass Packaging Sales (2021-2032) & (k units) Figure 16. Global Parenteral Drugs Glass Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Parenteral Drugs Glass Packaging Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Parenteral Drugs Glass Packaging Sales YoY (2021-2032) & (k units) Figure 19. Europe Parenteral Drugs Glass Packaging Sales YoY (2021-2032) & (k units) Figure 20. China Parenteral Drugs Glass Packaging Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Parenteral Drugs Glass Packaging Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Parenteral Drugs Glass Packaging Sales YoY (2021-2032) & (k units) Figure 23. Global Parenteral Drugs Glass Packaging Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Parenteral Drugs Glass Packaging Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Parenteral Drugs Glass Packaging Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Parenteral Drugs Glass Packaging Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Parenteral Drugs Glass Packaging Revenue Market Share by Type (2021-2032) Figure 29. Global Parenteral Drugs Glass Packaging Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Parenteral Drugs Glass Packaging Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Parenteral Drugs Glass Packaging Sales Market Share by Type (2021-2032) Figure 32. Global Parenteral Drugs Glass Packaging Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Parenteral Drugs Glass Packaging Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Parenteral Drugs Glass Packaging Revenue Market Share by Application (2021-2032) Figure 35. Global Parenteral Drugs Glass Packaging Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Parenteral Drugs Glass Packaging Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Parenteral Drugs Glass Packaging Sales Market Share by Application (2021-2032) Figure 38. North America Parenteral Drugs Glass Packaging Revenue Share by Type (2021-2032) Figure 39. North America Parenteral Drugs Glass Packaging Sales Share by Type (2021-2032) Figure 40. North America Parenteral Drugs Glass Packaging Revenue Share by Application (2021-2032) Figure 41. North America Parenteral Drugs Glass Packaging Sales Share by Application (2021-2032) Figure 42. North America Parenteral Drugs Glass Packaging Revenue Share by Country (2021-2032) Figure 43. North America Parenteral Drugs Glass Packaging Sales Share by Country (2021-2032) Figure 44. Europe Parenteral Drugs Glass Packaging Revenue Share by Type (2021-2032) Figure 45. Europe Parenteral Drugs Glass Packaging Sales Share by Type (2021-2032) Figure 46. Europe Parenteral Drugs Glass Packaging Revenue Share by Application (2021-2032) Figure 47. Europe Parenteral Drugs Glass Packaging Sales Share by Application (2021-2032) Figure 48. Europe Parenteral Drugs Glass Packaging Revenue Share by Country (2021-2032) Figure 49. Europe Parenteral Drugs Glass Packaging Sales Share by Country (2021-2032) Figure 50. China Parenteral Drugs Glass Packaging Revenue Share by Type (2021-2032) Figure 51. China Parenteral Drugs Glass Packaging Sales Share by Type (2021-2032) Figure 52. China Parenteral Drugs Glass Packaging Revenue Share by Application (2021-2032) Figure 53. China Parenteral Drugs Glass Packaging Sales Share by Application (2021-2032) Figure 54. Asia Parenteral Drugs Glass Packaging Revenue Share by Type (2021-2032) Figure 55. Asia Parenteral Drugs Glass Packaging Sales Share by Type (2021-2032) Figure 56. Asia Parenteral Drugs Glass Packaging Revenue Share by Application (2021-2032) Figure 57. Asia Parenteral Drugs Glass Packaging Sales Share by Application (2021-2032) Figure 58. Asia Parenteral Drugs Glass Packaging Revenue Share by Country (2021-2032) Figure 59. Asia Parenteral Drugs Glass Packaging Sales Share by Country (2021-2032) Figure 60. SAMEA Parenteral Drugs Glass Packaging Revenue Share by Type (2021-2032) Figure 61. SAMEA Parenteral Drugs Glass Packaging Sales Share by Type (2021-2032) Figure 62. SAMEA Parenteral Drugs Glass Packaging Revenue Share by Application (2021-2032) Figure 63. SAMEA Parenteral Drugs Glass Packaging Sales Share by Application (2021-2032) Figure 64. SAMEA Parenteral Drugs Glass Packaging Revenue Share by Country (2021-2032) Figure 65. SAMEA Parenteral Drugs Glass Packaging Sales Share by Country (2021-2032) Figure 66. Parenteral Drugs Glass Packaging Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Parenteral Drugs Glass Packaging Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Polyvinyl Chloride (PVC)
  • Polyolefin
Applications
  • Large Volume Parenteral (LVP)
  • Small Volume Parenteral (SVP)
Companies covered
  • Ypsomed Holding AG
  • Gerresheimer AG
  • SiO2 Medical Products
  • Schott AG
  • Ompi Stevanato Group
  • Becton Dickinson and Company
  • MeadWestvaco Corporation
  • Unilife Corporation Inc
  • West Pharmaceutical Services
  • Terumo Corporation
  • Berry Plastics Corporation
  • Owens-Illinois
  • RPC Group
  • Graphic Packaging Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Parenteral Drugs Glass Packaging Market by Type
  3. 1.2.1 Global Parenteral Drugs Glass Packaging Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Polyvinyl Chloride (PVC)
  5. 1.2.3 Polyolefin
  6. 1.3 Parenteral Drugs Glass Packaging Market by Application
  7. 1.3.1 Global Parenteral Drugs Glass Packaging Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Large Volume Parenteral (LVP)
  9. 1.3.3 Small Volume Parenteral (SVP)
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Parenteral Drugs Glass Packaging Market Dynamics
  1. 2.1 Parenteral Drugs Glass Packaging Industry Trends
  2. 2.2 Parenteral Drugs Glass Packaging Industry Drivers
  3. 2.3 Parenteral Drugs Glass Packaging Industry Opportunities and Challenges
  4. 2.4 Parenteral Drugs Glass Packaging Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Parenteral Drugs Glass Packaging Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Parenteral Drugs Glass Packaging Revenue by Region
  3. 3.2.1 Global Parenteral Drugs Glass Packaging Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Parenteral Drugs Glass Packaging Revenue by Region (2021-2026)
  5. 3.2.3 Global Parenteral Drugs Glass Packaging Revenue by Region (2027-2032)
  6. 3.2.4 Global Parenteral Drugs Glass Packaging Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Parenteral Drugs Glass Packaging Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Parenteral Drugs Glass Packaging Sales by Region
  9. 3.4.1 Global Parenteral Drugs Glass Packaging Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Parenteral Drugs Glass Packaging Sales by Region (2021-2026)
  11. 3.4.3 Global Parenteral Drugs Glass Packaging Sales by Region (2027-2032)
  12. 3.4.4 Global Parenteral Drugs Glass Packaging Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Parenteral Drugs Glass Packaging Revenue by Manufacturers
  2. 4.1.1 Global Parenteral Drugs Glass Packaging Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Parenteral Drugs Glass Packaging Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Parenteral Drugs Glass Packaging Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Parenteral Drugs Glass Packaging Sales by Manufacturers
  6. 4.2.1 Global Parenteral Drugs Glass Packaging Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Parenteral Drugs Glass Packaging Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Parenteral Drugs Glass Packaging Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Parenteral Drugs Glass Packaging Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Parenteral Drugs Glass Packaging Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Parenteral Drugs Glass Packaging Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Parenteral Drugs Glass Packaging Manufacturers, Product Type & Application
  13. 4.7 Global Parenteral Drugs Glass Packaging Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Parenteral Drugs Glass Packaging Market CR5 and HHI
  16. 4.8.2 2025 Parenteral Drugs Glass Packaging Tier 1, Tier 2, and Tier 3
5 Parenteral Drugs Glass Packaging Market by Type
  1. 5.1 Global Parenteral Drugs Glass Packaging Revenue by Type
  2. 5.1.1 Global Parenteral Drugs Glass Packaging Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Parenteral Drugs Glass Packaging Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Parenteral Drugs Glass Packaging Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Parenteral Drugs Glass Packaging Sales by Type
  6. 5.2.1 Global Parenteral Drugs Glass Packaging Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Parenteral Drugs Glass Packaging Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Parenteral Drugs Glass Packaging Sales Market Share by Type (2021-2032)
  9. 5.3 Global Parenteral Drugs Glass Packaging Price by Type
6 Parenteral Drugs Glass Packaging Market by Application
  1. 6.1 Global Parenteral Drugs Glass Packaging Revenue by Application
  2. 6.1.1 Global Parenteral Drugs Glass Packaging Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Parenteral Drugs Glass Packaging Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Parenteral Drugs Glass Packaging Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Parenteral Drugs Glass Packaging Sales by Application
  6. 6.2.1 Global Parenteral Drugs Glass Packaging Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Parenteral Drugs Glass Packaging Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Parenteral Drugs Glass Packaging Sales Market Share by Application (2021-2032)
  9. 6.3 Global Parenteral Drugs Glass Packaging Price by Application
7 Company Profiles
  1. 7.1 Ypsomed Holding AG
  2. 7.1.1 Ypsomed Holding AG Company Information
  3. 7.1.2 Ypsomed Holding AG Business Overview
  4. 7.1.3 Ypsomed Holding AG Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Ypsomed Holding AG Parenteral Drugs Glass Packaging Product Portfolio
  6. 7.1.5 Ypsomed Holding AG Recent Developments
  7. 7.2 Gerresheimer AG
  8. 7.2.1 Gerresheimer AG Company Information
  9. 7.2.2 Gerresheimer AG Business Overview
  10. 7.2.3 Gerresheimer AG Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Gerresheimer AG Parenteral Drugs Glass Packaging Product Portfolio
  12. 7.2.5 Gerresheimer AG Recent Developments
  13. 7.3 SiO2 Medical Products
  14. 7.3.1 SiO2 Medical Products Company Information
  15. 7.3.2 SiO2 Medical Products Business Overview
  16. 7.3.3 SiO2 Medical Products Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 SiO2 Medical Products Parenteral Drugs Glass Packaging Product Portfolio
  18. 7.3.5 SiO2 Medical Products Recent Developments
  19. 7.4 Schott AG
  20. 7.4.1 Schott AG Company Information
  21. 7.4.2 Schott AG Business Overview
  22. 7.4.3 Schott AG Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Schott AG Parenteral Drugs Glass Packaging Product Portfolio
  24. 7.4.5 Schott AG Recent Developments
  25. 7.5 Ompi Stevanato Group
  26. 7.5.1 Ompi Stevanato Group Company Information
  27. 7.5.2 Ompi Stevanato Group Business Overview
  28. 7.5.3 Ompi Stevanato Group Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Ompi Stevanato Group Parenteral Drugs Glass Packaging Product Portfolio
  30. 7.5.5 Ompi Stevanato Group Recent Developments
  31. 7.6 Becton Dickinson and Company
  32. 7.6.1 Becton Dickinson and Company Company Information
  33. 7.6.2 Becton Dickinson and Company Business Overview
  34. 7.6.3 Becton Dickinson and Company Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Becton Dickinson and Company Parenteral Drugs Glass Packaging Product Portfolio
  36. 7.6.5 Becton Dickinson and Company Recent Developments
  37. 7.7 MeadWestvaco Corporation
  38. 7.7.1 MeadWestvaco Corporation Company Information
  39. 7.7.2 MeadWestvaco Corporation Business Overview
  40. 7.7.3 MeadWestvaco Corporation Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 MeadWestvaco Corporation Parenteral Drugs Glass Packaging Product Portfolio
  42. 7.7.5 MeadWestvaco Corporation Recent Developments
  43. 7.8 Unilife Corporation Inc
  44. 7.8.1 Unilife Corporation Inc Company Information
  45. 7.8.2 Unilife Corporation Inc Business Overview
  46. 7.8.3 Unilife Corporation Inc Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Unilife Corporation Inc Parenteral Drugs Glass Packaging Product Portfolio
  48. 7.8.5 Unilife Corporation Inc Recent Developments
  49. 7.9 West Pharmaceutical Services
  50. 7.9.1 West Pharmaceutical Services Company Information
  51. 7.9.2 West Pharmaceutical Services Business Overview
  52. 7.9.3 West Pharmaceutical Services Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 West Pharmaceutical Services Parenteral Drugs Glass Packaging Product Portfolio
  54. 7.9.5 West Pharmaceutical Services Recent Developments
  55. 7.10 Terumo Corporation
  56. 7.10.1 Terumo Corporation Company Information
  57. 7.10.2 Terumo Corporation Business Overview
  58. 7.10.3 Terumo Corporation Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Terumo Corporation Parenteral Drugs Glass Packaging Product Portfolio
  60. 7.10.5 Terumo Corporation Recent Developments
  61. 7.11 Berry Plastics Corporation
  62. 7.11.1 Berry Plastics Corporation Company Information
  63. 7.11.2 Berry Plastics Corporation Business Overview
  64. 7.11.3 Berry Plastics Corporation Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Berry Plastics Corporation Parenteral Drugs Glass Packaging Product Portfolio
  66. 7.11.5 Berry Plastics Corporation Recent Developments
  67. 7.12 Owens-Illinois
  68. 7.12.1 Owens-Illinois Company Information
  69. 7.12.2 Owens-Illinois Business Overview
  70. 7.12.3 Owens-Illinois Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Owens-Illinois Parenteral Drugs Glass Packaging Product Portfolio
  72. 7.12.5 Owens-Illinois Recent Developments
  73. 7.13 RPC Group
  74. 7.13.1 RPC Group Company Information
  75. 7.13.2 RPC Group Business Overview
  76. 7.13.3 RPC Group Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 RPC Group Parenteral Drugs Glass Packaging Product Portfolio
  78. 7.13.5 RPC Group Recent Developments
  79. 7.14 Graphic Packaging Group
  80. 7.14.1 Graphic Packaging Group Company Information
  81. 7.14.2 Graphic Packaging Group Business Overview
  82. 7.14.3 Graphic Packaging Group Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Graphic Packaging Group Parenteral Drugs Glass Packaging Product Portfolio
  84. 7.14.5 Graphic Packaging Group Recent Developments
8 North America
  1. 8.1 North America Parenteral Drugs Glass Packaging Market Size by Type
  2. 8.1.1 North America Parenteral Drugs Glass Packaging Revenue by Type (2021-2032)
  3. 8.1.2 North America Parenteral Drugs Glass Packaging Sales by Type (2021-2032)
  4. 8.1.3 North America Parenteral Drugs Glass Packaging Price by Type (2021-2032)
  5. 8.2 North America Parenteral Drugs Glass Packaging Market Size by Application
  6. 8.2.1 North America Parenteral Drugs Glass Packaging Revenue by Application (2021-2032)
  7. 8.2.2 North America Parenteral Drugs Glass Packaging Sales by Application (2021-2032)
  8. 8.2.3 North America Parenteral Drugs Glass Packaging Price by Application (2021-2032)
  9. 8.3 North America Parenteral Drugs Glass Packaging Market Size by Country
  10. 8.3.1 North America Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Parenteral Drugs Glass Packaging Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Parenteral Drugs Glass Packaging Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Parenteral Drugs Glass Packaging Market Size by Type
  2. 9.1.1 Europe Parenteral Drugs Glass Packaging Revenue by Type (2021-2032)
  3. 9.1.2 Europe Parenteral Drugs Glass Packaging Sales by Type (2021-2032)
  4. 9.1.3 Europe Parenteral Drugs Glass Packaging Price by Type (2021-2032)
  5. 9.2 Europe Parenteral Drugs Glass Packaging Market Size by Application
  6. 9.2.1 Europe Parenteral Drugs Glass Packaging Revenue by Application (2021-2032)
  7. 9.2.2 Europe Parenteral Drugs Glass Packaging Sales by Application (2021-2032)
  8. 9.2.3 Europe Parenteral Drugs Glass Packaging Price by Application (2021-2032)
  9. 9.3 Europe Parenteral Drugs Glass Packaging Market Size by Country
  10. 9.3.1 Europe Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Parenteral Drugs Glass Packaging Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Parenteral Drugs Glass Packaging Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Parenteral Drugs Glass Packaging Market Size by Type
  2. 10.1.1 China Parenteral Drugs Glass Packaging Revenue by Type (2021-2032)
  3. 10.1.2 China Parenteral Drugs Glass Packaging Sales by Type (2021-2032)
  4. 10.1.3 China Parenteral Drugs Glass Packaging Price by Type (2021-2032)
  5. 10.2 China Parenteral Drugs Glass Packaging Market Size by Application
  6. 10.2.1 China Parenteral Drugs Glass Packaging Revenue by Application (2021-2032)
  7. 10.2.2 China Parenteral Drugs Glass Packaging Sales by Application (2021-2032)
  8. 10.2.3 China Parenteral Drugs Glass Packaging Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Parenteral Drugs Glass Packaging Market Size by Type
  2. 11.1.1 Asia Parenteral Drugs Glass Packaging Revenue by Type (2021-2032)
  3. 11.1.2 Asia Parenteral Drugs Glass Packaging Sales by Type (2021-2032)
  4. 11.1.3 Asia Parenteral Drugs Glass Packaging Price by Type (2021-2032)
  5. 11.2 Asia Parenteral Drugs Glass Packaging Market Size by Application
  6. 11.2.1 Asia Parenteral Drugs Glass Packaging Revenue by Application (2021-2032)
  7. 11.2.2 Asia Parenteral Drugs Glass Packaging Sales by Application (2021-2032)
  8. 11.2.3 Asia Parenteral Drugs Glass Packaging Price by Application (2021-2032)
  9. 11.3 Asia Parenteral Drugs Glass Packaging Market Size by Country
  10. 11.3.1 Asia Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Parenteral Drugs Glass Packaging Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Parenteral Drugs Glass Packaging Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Parenteral Drugs Glass Packaging Market Size by Type
  2. 12.1.1 SAMEA Parenteral Drugs Glass Packaging Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Parenteral Drugs Glass Packaging Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Parenteral Drugs Glass Packaging Price by Type (2021-2032)
  5. 12.2 SAMEA Parenteral Drugs Glass Packaging Market Size by Application
  6. 12.2.1 SAMEA Parenteral Drugs Glass Packaging Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Parenteral Drugs Glass Packaging Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Parenteral Drugs Glass Packaging Price by Application (2021-2032)
  9. 12.3 SAMEA Parenteral Drugs Glass Packaging Market Size by Country
  10. 12.3.1 SAMEA Parenteral Drugs Glass Packaging Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Parenteral Drugs Glass Packaging Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Parenteral Drugs Glass Packaging Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Parenteral Drugs Glass Packaging Value Chain Analysis
  2. 13.1.1 Parenteral Drugs Glass Packaging Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Parenteral Drugs Glass Packaging Production Mode & Process
  6. 13.2 Parenteral Drugs Glass Packaging Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Parenteral Drugs Glass Packaging Distributors
  9. 13.2.3 Parenteral Drugs Glass Packaging Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research